⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MGNX News
MacroGenics, Inc.
Ladenburg Thalmann Expands Biotechnology Equity Research Team with Addition of Two Senior Analysts, Rick Bienkowski, Ph.D. and Caroline Palomeque
businesswire.com
RBC
BMRA
MGNX
OPY
GS
Form 8-K
sec.gov
MGNX
MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum
globenewswire.com
MGNX
Form 8-K
sec.gov
MGNX
MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation
globenewswire.com
MGNX
Form 8-K
sec.gov
MGNX
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
globenewswire.com
MGNX
PARP Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
AZN
MRK
JNJ
PFE
ABBV
GSK
ALLR
SNY
CURI
ORIC
EXEL
ABSI
LLY
TLX
FPH
BMY
SNX
XNCR
ZENA
ARVN
MGNX
DASH
VERU
GILD
EVGN
GEN
AMGN
MIR
RXRX
BG
MTX
BIO
Form 8-K
sec.gov
MGNX
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
globenewswire.com
MGNX